Vera Therapeutics Inc
NASDAQ:VERA
Income Statement
Earnings Waterfall
Vera Therapeutics Inc
Revenue
|
0
USD
|
Operating Expenses
|
-102m
USD
|
Operating Income
|
-102m
USD
|
Other Expenses
|
6m
USD
|
Net Income
|
-96m
USD
|
Income Statement
Vera Therapeutics Inc
Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||
Operating Expenses |
(48)
|
(51)
|
(54)
|
(59)
|
(34)
|
(44)
|
(56)
|
(74)
|
(91)
|
(105)
|
(112)
|
(109)
|
(102)
|
|
Selling, General & Administrative |
(4)
|
(5)
|
(6)
|
(9)
|
(12)
|
(15)
|
(17)
|
(19)
|
(22)
|
(24)
|
(24)
|
(24)
|
(24)
|
|
Research & Development |
(44)
|
(47)
|
(48)
|
(50)
|
(22)
|
(32)
|
(39)
|
(55)
|
(69)
|
(82)
|
(88)
|
(84)
|
(78)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(48)
N/A
|
(51)
-7%
|
(54)
-5%
|
(59)
-9%
|
(34)
+41%
|
(44)
-28%
|
(56)
-27%
|
(74)
-32%
|
(91)
-23%
|
(105)
-16%
|
(112)
-7%
|
(109)
+3%
|
(102)
+6%
|
|
Pre-Tax Income | ||||||||||||||
Interest Income Expense |
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
1
|
2
|
3
|
4
|
4
|
|
Non-Reccuring Items |
(4)
|
(3)
|
(0)
|
1
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
1
|
2
|
2
|
2
|
2
|
|
Pre-Tax Income |
(53)
N/A
|
(56)
-4%
|
(55)
+0%
|
(59)
-6%
|
(33)
+44%
|
(45)
-38%
|
(56)
-25%
|
(73)
-30%
|
(89)
-21%
|
(102)
-15%
|
(107)
-5%
|
(103)
+4%
|
(96)
+7%
|
|
Net Income | ||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
Income from Continuing Operations |
(53)
|
(56)
|
(55)
|
(59)
|
(33)
|
(45)
|
(56)
|
(73)
|
(89)
|
(102)
|
(107)
|
(103)
|
(96)
|
|
Net Income (Common) |
(53)
N/A
|
(56)
-4%
|
(55)
+0%
|
(59)
-6%
|
(33)
+44%
|
(45)
-38%
|
(56)
-25%
|
(73)
-30%
|
(89)
-21%
|
(102)
-15%
|
(107)
-5%
|
(103)
+4%
|
(96)
+7%
|
|
EPS (Diluted) |
-2.61
N/A
|
-2.72
-4%
|
-2.6
+4%
|
-2.75
-6%
|
-1.53
+44%
|
-1.85
-21%
|
-2.08
-12%
|
-2.69
-29%
|
-3.35
-25%
|
-2.7
+19%
|
-2.42
+10%
|
-2.31
+5%
|
-2.25
+3%
|